Cipher PharmaceuticalsCPHRF 96 FCF Yield % is 9.81 as of Jun. 27, 2026, which is 47% below its 10-year median of 18.68. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.20 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Cipher Pharmaceuticals ranks better than 86.17% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Cipher Pharmaceuticals FCF Yield % Related Terms
Cipher Pharmaceuticals FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cipher Pharmaceuticals FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Cipher Pharmaceuticals's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cipher Pharmaceuticals (CPHRF) has a FCF Yield % of 9.81 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cipher Pharmaceuticals and its competitors. This is 47% below median its historical median of 18.68. Over the past decade, Cipher Pharmaceuticals' FCF Yield % has ranged from 3.86 to 88.36. According to the industry distribution chart, Cipher Pharmaceuticals ranks #139 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 13.8%.
Is Cipher Pharmaceuticals' FCF Yield % too high?
Cipher Pharmaceuticals' current FCF Yield % of 9.81 is 47% below median its 10-year median of 18.68. Over the past 10 years, this metric has ranged from a low of 3.86 to a high of 88.36. The Drug Manufacturers industry median FCF Yield % is 0.67. Cipher Pharmaceuticals' value of 9.81 is 1364.2% above this industry median. Based on the distribution chart, Cipher Pharmaceuticals ranks #139 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cipher Pharmaceuticals ranks #139 out of 1005 companies for FCF Yield %. This places Cipher Pharmaceuticals in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.67. Cipher Pharmaceuticals' value of 9.81 is 1364.2% above this benchmark. Historically, Cipher Pharmaceuticals' own FCF Yield % has ranged from 3.86 to 88.36 over the past decade. While the company's 10-year median is 18.68 vs. the industry median of 0.67, Cipher Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cipher Pharmaceuticals's current FCF Yield % of 9.81 is 1364.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cipher Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cipher Pharmaceuticals's current FCF Yield % is 9.81, which is 47% below median its own 10-year median of 18.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.20, compared to a current price of $11.77 — trading 3.5% below its estimated fair value. The current FCF Yield % is 9.81, which is 47% below median its 10-year median of 18.68 and 1364.2% above the Drug Manufacturers industry median of 0.67. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current FCF Yield % is 9.81 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?
Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued.
The current stock price of $11.77 is trading 3.5% below its estimated GF Value™ of $12.20.
GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.
Key valuation signals for CPHRF:
FCF Yield %: 9.81 (47% below median its 10-year median of 18.68)
GF Value™: $12.20 vs. price of $11.77 (3.5% below fair value)
Industry Position: 1364.2% above the Drug Manufacturers median (#139 of 1005)
No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score
Get the complete analysis for CPHRF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPHRF has been successfully added to your 
